Tasly Pharmaceutical Group Co., Ltd.
Leading Chinese pharmaceutical conglomerate specialising in traditional Chinese medicine and card…
Leading Chinese pharmaceutical conglomerate specialising in traditional Chinese medicine and cardio-cerebrovascular drugs; products distributed to over 40 countries. Operates R&D centres and manufacturing plants certified to international GMP standards.
- Type
- Manufacturer
- Location
- Tianjin, China
- Founded
- 1994
- Website
- tasly.com
- Categories
- Medical & Healthcare Supplies, Supplements & Wellness
- Markets
- China, United States, Germany, Australia, Canada
Verified facts
- domain-registered (green), checked 2026-08-12 Domain registry record
- sanctions-clear (green), checked 2026-08-12 OpenSanctions
- debarment-clear (green), checked 2026-08-12 OpenSanctions
- facility-registered (green), checked 2026-08-19 BPOM (Indonesian Food and Drug Authority), public register of manufacturing facilities behind product registrations (Sarana)
- gmp-certified (green), checked 2020-12-09 EudraGMDP, EU register of GMP certificates (EMA)
Claimed certifications
- ISO 9001, Quality Management IAF CertSearch
- Good Manufacturing Practice
- ISO 14001, Environmental Management IAF CertSearch
Import rules for these goods
- Food supplements sold in the EU follow Directive 2002/46/EC: most member states require a notification to the national authority before the first sale. European Commission (supplements)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)